All results

109 results

• Addition of Pembrolizumab to Usual Intravesical Gemcitabine for Treatment of BCG-Unresponsive NMIBC

  This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does…

  Ages

  18 Years - N/A

  Sexes

  All

• Armata

  Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Escalation Study of the Safety, Tolerability, and Efficacy of Intravenous AP…

  Ages

  18 Years - N/A

  Sexes

  All

• Aroma

  ### The primary objectives of the study are: * To longitudinally characterize the long-term effectiveness of DUPIXENT® through assessment of patient-reported…

  Ages

  18 Years - N/A

  Sexes

  All

• Atacicept in Subjects With IgA Nephropathy

  A Phase 3 Study with Atacicept in Subjects With IgA Nephropathy (ORIGIN 3) This is a multi-part study comprising of the original Phase 2b study (active, no…

  Ages

  18 Years - N/A

  Sexes

  All

• BIIB059

  In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic lupus erythematosus (SLE). The study…

  Ages

  18 Years - N/A

  Sexes

  All

• BIO-LIBRA

  The purpose of this registry is to prospectively assess outcomes of device-treated ventricular tachyarrhythmias and all-cause mortality in non-ischemic…

  Ages

  18 Years - N/A

  Sexes

  All

• BOSTON 3

  The objective of the trial is to assess the long-term safety and efficacy of L-CsA plus Standard of Care (SoC) in the treatment of BOS in single (SLT) and…

  Ages

  18 Years - N/A

  Sexes

  All

• Bio-BOOST

  BioBOOST is a multicenter, observational study of the effect of derangements in brain physiologic parameters on brain injury biomarker levels in patients with…

  Ages

  18 Years - N/A

  Sexes

  All

• BvV

  The Beads vs Vac trial is a multi-centre randomized controlled trial of 312 participants with a severe open tibia fracture requiring multiple irrigation and…

  Ages

  18 Years - N/A

  Sexes

  All

• CLBS16

  This clinical trial will explore the efficacy and safety of GCSF-mobilized autologous CD34+ cells for the treatment of CMD in adults currently experiencing…

  Ages

  18 Years - N/A

  Sexes

  All